# Athimalaipet V Ramanan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/athimalaipet-v-ramanan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 12,517 |
| Field | Autoimmune and Inflammatory Disorders Research |
| h-index | 53 |
| i10-index | 158 |
| Last Known Institution | Bristol Royal Hospital for Children |
| OpenAlex ID | https://openalex.org/A5015700716 |
| ORCID iD | 0000-0001-8663-2401 |
| Works | 322 |

## Researcher papers

- [Recommendations for the management of hemophagocytic lymphohistiocytosis in adults](https://scholariq.org/papers/recommendations-for-the-management-of-hemophagocytic-lymphohistiocytosis-in/)
- [2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative](https://scholariq.org/papers/2016-classification-criteria-for-macrophage-activation-syndrome-complicating/)
- [Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19](https://scholariq.org/papers/association-between-administration-of-il-6-antagonists-and-mortality-among/)
- [Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis](https://scholariq.org/papers/adalimumab-plus-methotrexate-for-uveitis-in-juvenile-idiopathic-arthritis/)
- [2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis](https://scholariq.org/papers/2016-classification-criteria-for-macrophage-activation-syndrome-complicating-2/)
- [A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process](https://scholariq.org/papers/a-national-consensus-management-pathway-for-paediatric-inflammatory-multisystem/)
- [Chronic recurrent multifocal osteomyelitis (CRMO) – advancing the diagnosis](https://scholariq.org/papers/chronic-recurrent-multifocal-osteomyelitis-crmo-advancing-the-diagnosis/)
- [The diagnostic significance of soluble CD163 and soluble interleukin‐2 receptor α‐chain in macrophage activation syndrome and untreated new‐onset systemic juvenile idiopathic arthritis](https://scholariq.org/papers/the-diagnostic-significance-of-soluble-cd163-and-soluble-interleukin-2-receptor/)
- [Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial](https://scholariq.org/papers/aspirin-in-patients-admitted-to-hospital-with-covid-19-recovery-a-randomised/)
- [Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis](https://scholariq.org/papers/guidance-on-noncorticosteroid-systemic-immunomodulatory-therapy-in-noninfectious/)
- [Changing evidence over time: updated meta-analysis regarding anti-TNF efficacy in childhood chronic uveitis](https://scholariq.org/papers/changing-evidence-over-time-updated-meta-analysis-regarding-anti-tnf-efficacy-in/)

## Researcher topics

- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)
- [Ocular Diseases and Behçet’s Syndrome](https://scholariq.org/topics/ocular-diseases-and-behcet-s-syndrome/)
- [Adolescent and Pediatric Healthcare](https://scholariq.org/topics/adolescent-and-pediatric-healthcare/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Inflammasome and immune disorders](https://scholariq.org/topics/inflammasome-and-immune-disorders/)

## Researcher university

- [Bristol Royal Hospital for Children](https://scholariq.org/institutions/bristol-royal-hospital-for-children/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.